Lineage Cell Therapeutics In shares owned by Long Focus Capital Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Long Focus Capital Management
from 13F filings
Historical chart of Long Focus Capital Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Long Focus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Long Focus Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $234k | 215k | 1.09 |
| 2023-09-30 | $254k | 215k | 1.18 |
| 2023-06-30 | $303k | 215k | 1.41 |
| 2023-03-31 | $323k | 215k | 1.50 |
| 2022-12-31 | $252k | 215k | 1.17 |
| 2022-09-30 | $243k | 215k | 1.13 |
| 2022-06-30 | $340k | 215k | 1.58 |
| 2022-03-31 | $331k | 215k | 1.54 |
| 2021-12-31 | $527k | 215k | 2.45 |
More positions owned by Long Focus Capital Management
Antero Res (AR)
View all positions for Long Focus Capital Management